| Net Cash Provided by (Used in) Operating Activities |
$1,798,125 |
USD |
5.4% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$164,070 |
USD |
-97% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
10,416,721 |
shares |
33% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,634,055 |
USD |
-137% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,095,712 |
USD |
-51% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$1,015 |
USD |
-69% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$3,656,627 |
USD |
76% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$3,657,073 |
USD |
76% |
Q4 2024 |
FY 2024 |
| Depreciation |
$431 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,650,540 |
USD |
85% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$23,755,000 |
USD |
26% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$446 |
USD |
-1.3% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$837,860 |
USD |
-28% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$22,081 |
USD |
-94% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |